How large is the pimozide tablet market, and what is its growth trajectory?
The pimozide tablet market size has grown strongly in recent years. It will grow from $1.67 $ billion in 2024 to $1.84 $ billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increased diagnosis rates of mental disorders, rise in mental health awareness, improved insurance coverage, improved healthcare infrastructure, and an increasing geriatric population.
The pimozide tablet market size is expected to see strong growth in the next few years. It will grow to $2.66 $ billion in 2029 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to improved access to mental health services, rising disposable incomes, entry of generic versions of mental disorder drugs, new regulatory approvals and label expansions, and improved management and reduction of side effects. Major trends in the forecast period include technological advancements, the rise of e-commerce platforms, advances in diagnostic techniques for psychiatric disorders, market penetration in emerging economies, and the growth of telemedicine and online consultations.
Get Your Free Sample of The Global Pimozide Tablet Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19655&type=smp
What are the key forces behind the pimozide tablet market’s growth in recent years?
The rising prevalence of psychiatric disorders is expected to propel the growth of the pimozide tablet market going forward. Psychiatric disorders are mental health conditions characterized by significant disturbances in thoughts, emotions, or behaviors, leading to distress or impaired functioning. The rising prevalence of psychiatric disorders is primarily attributed to factors such as increased stress levels, changing societal norms, better awareness and diagnosis, and genetic predispositions. Pimozide tablets are used in psychiatric disorders to manage symptoms such as delusions and tics by blocking dopamine receptors, thereby helping to reduce abnormal brain activity. For instance, in February 2022, according to the NCD Alliance, a Switzerland-based civil society network, 55 million people are living with dementia globally, with nearly 10 million new cases emerging each year. This number is expected to rise to approximately 75 million by 2030 and 139 million by 2050. Therefore, the rising prevalence of psychiatric disorders is driving the pimozide tablet market.
What are the major segments of the pimozide tablet market?
The pimozide tabletmarket covered in this report is segmented –
1) By Type: 1 Milligram, 2 Milligram, 4 Milligram
2) By Distribution Channel: Online, Offline
3) By Application: Tourette’s Syndrome, Chronic Schizophrenia
4) By End User: Hospitals, Clinics, Home Use
Subsegments:
1) By 1 Milligram: Bottle Packaging, Blister Packaging, Unit Dose Packaging
2) By 2 Milligram: Bottle Packaging, Blister Packaging, Unit Dose Packaging
3) By 4 Milligram: Bottle Packaging, Blister Packaging, Unit Dose Packaging
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/pimozide-tablet-global-market-report
Which companies dominate the pimozide tablet market?
Major companies operating in the pimozide tablet market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Bristol-Myers Squibb, GlaxoSmithKline plc, C.H. Boehringer Sohn AG & Co. KG, Teva Pharmaceutical Industries Ltd., Hetero Drugs, Sun Pharmaceutical Industries Ltd., Jazz Pharmaceuticals, Aurobindo Pharma, Cipla Limited, Apotex Inc., H. Lundbeck A/S, Dr. Reddy’s Laboratories, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Endo International, Lupin Limited, Zydus Cadila, Alkem Laboratories, Torrent Pharmaceuticals, Glenmark Pharmaceuticals, Mallinckrodt Pharmaceuticals, Jubilant Life Sciences, Alembic Pharmaceuticals, Wockhardt, AA Pharma, Taj Pharmaceuticals
What are the key regional dynamics of the pimozide tablet market, and which region leads in market share?
North America was the largest region in the pimozide tablet market in 2024. The regions covered in the pimozide tablet market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Pimozide Tablet Market Report 2025 Offer?
The pimozide tablet market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Pimozide tablets are antipsychotic medications primarily used to treat Tourette’s syndrome and chronic psychosis. They work by blocking dopamine receptors in the brain, which helps reduce symptoms such as tics and hallucinations. These tablets are typically prescribed when other treatments have not been effective.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19655
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
